Log in
NYSEAMERICAN:PFNX

Pfenex Stock Forecast, Price & News

$12.86
+0.18 (+1.42 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$12.68
Now: $12.86
$12.86
50-Day Range N/A
52-Week Range
$5.26
Now: $12.86
$14.00
Volume599,134 shs
Average Volume446,531 shs
Market Capitalization$441.06 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidates include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis; and novel anthrax vaccine candidates, such as Px563L and RPA563 that have completed Phase Ia clinical study. The company also develops PF582, a biosimilar candidate to Lucentis; PF529, a biosimilar to Neulasta; and hematology/oncology products, including PF743, a recombinant crisantaspase, as well as PF745, a recombinant crisantaspase with half-life extension technology. In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.
Read More
Pfenex logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.91 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:PFNX
Previous SymbolNYSEMKT:PFNX
CUSIPN/A
CIKN/A
Phone+1-858-3524400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees71
Market Cap$441.06 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$12.86
+0.18 (+1.42 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PFNX News and Ratings via Email

Sign-up to receive the latest news and ratings for PFNX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Pfenex (NYSEAMERICAN:PFNX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Pfenex?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfenex in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Pfenex
.

When is Pfenex's next earnings date?

Pfenex is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Pfenex
.

How were Pfenex's earnings last quarter?

Pfenex Inc (NYSEAMERICAN:PFNX) released its earnings results on Thursday, August, 6th. The biotechnology company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.27) by $0.03. The biotechnology company had revenue of $0.78 million for the quarter, compared to analyst estimates of $2.72 million.
View Pfenex's earnings history
.

What price target have analysts set for PFNX?

6 equities research analysts have issued 1 year target prices for Pfenex's shares. Their forecasts range from $13.00 to $19.00. On average, they anticipate Pfenex's share price to reach $15.00 in the next year. This suggests a possible upside of 16.6% from the stock's current price.
View analysts' price targets for Pfenex
.

Are investors shorting Pfenex?

Pfenex saw a drop in short interest in August. As of August 31st, there was short interest totaling 590,100 shares, a drop of 24.8% from the August 15th total of 785,100 shares. Based on an average daily volume of 604,900 shares, the days-to-cover ratio is presently 1.0 days.
View Pfenex's Short Interest
.

Who are some of Pfenex's key competitors?

What other stocks do shareholders of Pfenex own?

Who are Pfenex's key executives?

Pfenex's management team includes the following people:
  • Mr. Evert B. Schimmelpennink, CEO, Pres, Sec. & Director (Age 47)
  • Ms. Patricia Lady C.M.A., CPA, M.B.A., CPA, MBA CMA, Chief Accounting Officer (Age 61)
  • Mr. Patrick K. Lucy, Chief Bus. Officer (Age 51)
  • Dr. Hubert C. Chen, Advisor (Age 50)
  • Ms. Susan A. Knudson, Chief Financial Officer (Age 55)

What is Pfenex's stock symbol?

Pfenex trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PFNX."

Who are Pfenex's major shareholders?

Pfenex's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Blair William & Co. IL (8.87%), First Light Asset Management LLC (6.85%), RK Capital Management LLC (3.27%), Telemark Asset Management LLC (2.92%), Jacobs Levy Equity Management Inc. (0.83%) and Charles Schwab Investment Management Inc. (0.81%).
View institutional ownership trends for Pfenex
.

Which major investors are selling Pfenex stock?

PFNX stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., AQR Capital Management LLC, Falcon Point Capital LLC, Nuveen Asset Management LLC, Man Group plc, Delta Investment Management LLC, UBS Group AG, and ClariVest Asset Management LLC.
View insider buying and selling activity for Pfenex
.

Which major investors are buying Pfenex stock?

PFNX stock was bought by a variety of institutional investors in the last quarter, including RK Capital Management LLC, Blair William & Co. IL, Telemark Asset Management LLC, Jacobs Levy Equity Management Inc., Goldman Sachs Group Inc., Bank of Montreal Can, Two Sigma Advisers LP, and Schonfeld Strategic Advisors LLC.
View insider buying and selling activity for Pfenex
.

How do I buy shares of Pfenex?

Shares of PFNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pfenex's stock price today?

One share of PFNX stock can currently be purchased for approximately $12.86.

How big of a company is Pfenex?

Pfenex has a market capitalization of $441.06 million. Pfenex employs 71 workers across the globe.

What is Pfenex's official website?

The official website for Pfenex is www.pfenex.com.

How can I contact Pfenex?

Pfenex's mailing address is 10790 Roselle St, SAN DIEGO, CA 92121-1508, United States. The biotechnology company can be reached via phone at +1-858-3524400.

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.